Who would Vote Against Patients’ Right to Try?

Kevin Freiert

Kevin is the Principal of Salem Oaks Enterprises, LLC. Committed to working with patients, their advocates, biopharmaceutical companies, regulators and other stakeholders to develop educational tools that help patients bridge the gap between themselves and Biopharma R&D.

Works Cited

Center for Information and Study on Clinical Research Participation (CISCRP) 2017 Perceptions and Insights Study: Public Perceptions of Clinical Research.

Leave a Comment